Skip to main content
. 2021 May 20;12:650535. doi: 10.3389/fneur.2021.650535

Table 2.

Longitudinal change of prospective outcomes following nusinersen treatment.

Measure Time/comparison N Estimate (baseline/change from baseline)# 95% CI p-value
Primary outcome
MVICT (Kg) Baseline 13 6.75 4.3, 9.19
2 months—baseline 13 0.36 −0.2, 0.92 0.2051
6 months—baseline 13 0.29 −0.27, 0.85 0.3057
10 months—baseline 13 0.52 −0.04, 1.08 0.0672
14 months—baseline 9 0.2 −0.43, 0.84 0.5222
Functional scales
HFMSE Baseline 13 45.85 40.41, 51.28
2 months—baseline 13 2.77 0.84, 4.69 0.0058
6 months—baseline 13 2.46 0.54, 4.39 0.0134
10 months—baseline 13 2.08 0.15, 4.00 0.0351
14 months—baseline 10 2.6 0.5, 4.69 0.0165
SMA-FRS Baseline 13 31.23 29.47, 32.99
2 months—baseline 13 1.69 0.42, 2.96 0.0102
6 months—aseline 13 1.77 0.5, 3.04 0.0074
10 months—baseline 13 1.23 −0.04, 2.50 0.0575
14 months—baseline 11 1.57 0.23, 2.92 0.0224
Physical function
Six minute walk test (meters) Baseline 11 262.88 171.42, 354.35
2 months—baseline 13 19.49 2.91, 36.07 0.0223
6 months—baseline 13 25.27 8.69, 41.85 0.0037
10 months—baseline 13 19.19 2.61, 35.77 0.0243
14 months—baseline 10 15.88 −2.16, 33.92 0.0829
Forced vital capacity (liters) Baseline 13 4.07 3.38, 4.77
2 months—baseline 13 0.07 −0.04, 0.18 0.2206
6 months—baseline 13 0.16 0.04, 0.27 0.0081
10 months—baseline 13 0.12 0.01, 0.24 0.0332
14 months—baseline 10 0.17 0.05, 0.3 0.0072
Electrophysiological measures of motor unit connectivity
Compound muscle action potential amplitude (millivolts) Baseline 13 8.42 7.16, 9.68
2 months—baseline 13 0.08 −0.22, 0.39 0.5766
6 months—baseline 13 0.35 0.05, 0.66 0.0231
10 months—baseline 13 0.41 0.10, 0.71 0.0095
14 months—baseline 10 0.47 0.14, 0.80 0.0060
Average single motor unit potential amplitude (microvolts) Baseline 11 80.83 71.14, 90.51
2 months—baseline 13 5.13 0.35, 9.91 0.0359
6 months—baseline 13 3.76 −1.02, 8.55 0.1196
10 months—baseline 13 6.69 1.91, 11.47 0.0072
14 months—baseline 10 8.93 3.73, 14.13 0.0012
Motor unit number estimation Baseline 11 106.17 88.14, 124.21
2 months—baseline 13 −2.17 −7.83, 3.48 0.4419
6 months—baseline 13 −1.64 −7.29, 4.01 0.5623
10 months—baseline 13 −2.48 −8.13, 3.17 0.3806
14 months—baseline 10 −5.22 −11.37, 0.93 0.0940
#

Positive values indicate increase compared to baseline, and negative values indicate decrease from baseline at each time point (2, 6, 10, and 14 months).